Affordable Insulin Now Act
Official title: A bill to provide for appropriate cost-sharing for insulin products covered under Medicare part D and private health plans.
More subjectsShow fewer subjects
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Read twice and referred to the Committee on Finance.
Affordable Insulin Now Act
This bill limits cost-sharing for insulin under private health insurance and the Medicare prescription drug benefit.
Specifically, the bill caps cost-sharing under private health insurance for a month's supply of selected insulin products at $35 or 25% of a plan's negotiated price (after any price concessions), whichever is less, beginning in 2023.
The bill caps cost-sharing under the Medicare prescription drug benefit for a month's supply of covered insulin products at (1) $35 between October 1, 2022, and January 1, 2024; and (2) $35 or 25% of a plan's negotiated price, whichever is less, beginning in 2024. The bill provides funds for FY2022 for the Centers for Medicare & Medicaid Services (CMS) to implement the bill.
Currently, the CMS is testing a voluntary model under the Medicare prescription drug benefit (the Part D Senior Savings Model) in which the copayment for a month's supply of insulin is capped at $35 through participating plans. The model is set to expire on December 31, 2025.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 3700: Affordable Insulin Now Act. 117th Congress. Open America. https://openamerica.io/bill/117-S-3700/
"S. 3700: Affordable Insulin Now Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-3700/.
S. 3700, 117th Cong. (2026), https://openamerica.io/bill/117-S-3700/.
[S. 3700: Affordable Insulin Now Act](https://openamerica.io/bill/117-S-3700/)